LFG
RYTM icon

Larson Financial Group’s Rhythm Pharmaceuticals RYTM Stock Holding History

Larson Financial Group’s Portfolio RYTM Stock Details RYTM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$11.9K Buy
107
+55
+106% +$4.97K ﹤0.01% 2299
2026
Q1 		$4.52K Sell
52
-25
-32% -$2.43K ﹤0.01% 2655
2025
Q4 		$8.24K Buy
77
+49
+175% +$5.2K ﹤0.01% 2227
2025
Q3 		$2.83K Buy
+28
New +$2.6K ﹤0.01% 2570

Other funds holding RYTM

RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Larson Financial Group's RYTM Position: Q2 2026 in Review

Larson Financial Group increased its Rhythm Pharmaceuticals (RYTM) stake by 106% in Q2 2026, buying an estimated $4.97K and bringing the position to 107 shares worth $11.9K. The position accounts for ﹤0.01% of the portfolio, ranked #2299.

Larson Financial Group first reported a position in RYTM in Q3 2025 and has held it in 4 quarters since. 304 funds tracked by Wall St. Rank hold RYTM as of Q2 2026.

  • Larson Financial Group held 107 shares of Rhythm Pharmaceuticals worth $11.9K as of Q2 2026.
  • Larson Financial Group bought 55 Rhythm Pharmaceuticals shares in Q2 2026, an estimated $4.97K.
  • Rhythm Pharmaceuticals made up ﹤0.01% of Larson Financial Group's portfolio in Q2 2026, its #2299 holding.
  • Larson Financial Group first reported a position in Rhythm Pharmaceuticals in Q3 2025 and has held it in 4 quarters since.
  • 304 funds tracked by Wall St. Rank held Rhythm Pharmaceuticals as of Q2 2026.

Based on Larson Financial Group's 13F filing for Q2 2026, filed 14 Aug 2026.